Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/22658
Title: Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel Disease.
Authors: Peverelle, Matthew R;Mills, Christopher D;Testro, Adam G;Gow, Paul J;De Cruz, Peter P
Affiliation: Department of Medicine, Austin Academic Centre, University of Melbourne, Melbourne, Australia
Department of Gastroenterology, Austin Health, Heidelberg, Victoria, Australia
Issue Date: 20-Feb-2020
EDate: 2020-02-20
Citation: Inflammatory bowel diseases 2020; online first: 20 February
URI: http://ahro.austin.org.au/austinjspui/handle/1/22658
DOI: 10.1093/ibd/izaa027
ORCID: 0000-0003-0136-6699
0000-0002-3399-7236
PubMed URL: 32076720
Type: Journal Article
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.